Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verny

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Archives of Neurology|August 26, 1998
Pharmacological therapy in progressive supranuclear palsyK Kompoliti, C G Goetz, I Litvan, et al.
Annales De Cardiologie Et D'Angeiologie|May 1, 1991
[Cerebral vascular aging (excluding innervation)]M Verny, D Seilhean, C Duyckaerts, et al.
Revue Neurologique|June 22, 2021
A case of type 1 achalasia associated with Parkinson's diseaseM Cheval, C Villain, P Gay, et al.
La Revue De Medecine Interne|December 20, 2005
[Medical comorbidity in Alzheimer's disease: baseline characteristics of the REAL.FR Cohort]M-A Artaz, J Boddaert, E Hériche-Taillandier, et al.
Acta Neuropathologica|January 1, 1991
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer typeS Flament, A Delacourte, M Verny, et al.
Annales De Medecine Interne|January 1, 1997
[Dementia syndromes and length of stay of elderly patients in internal medicine]E Pautas, M Verny, J Holstein, et al.
Presse Medicale (Paris, France : 1983)|May 29, 2000
[Myasthenia in the aged: a case with unusually late onset]E Pautas, O Milleron, J P Bouchon, et al.
Neuroscience Letters|November 13, 1990
Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and agingJ J Hauw, M Verny, P Delaère, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammonium-propyl-cyclam, and N-[Triethylammonium]-3-propyl-[15]ane-N5, potential cartilage imaging agentsJ C Maurizis, M Rapp, C Nicolas, et al.
Acta Neuropathologica|January 1, 1996
Progressive supranuclear palsy: a clinicopathological study of 21 casesM Verny, K A Jellinger, J J Hauw, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Archives of Neurology|August 26, 1998
Pharmacological therapy in progressive supranuclear palsyK Kompoliti, C G Goetz, I Litvan, et al.
Annales De Cardiologie Et D'Angeiologie|May 1, 1991
[Cerebral vascular aging (excluding innervation)]M Verny, D Seilhean, C Duyckaerts, et al.
Revue Neurologique|June 22, 2021
A case of type 1 achalasia associated with Parkinson's diseaseM Cheval, C Villain, P Gay, et al.
La Revue De Medecine Interne|December 20, 2005
[Medical comorbidity in Alzheimer's disease: baseline characteristics of the REAL.FR Cohort]M-A Artaz, J Boddaert, E Hériche-Taillandier, et al.
Acta Neuropathologica|January 1, 1991
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer typeS Flament, A Delacourte, M Verny, et al.
Annales De Medecine Interne|January 1, 1997
[Dementia syndromes and length of stay of elderly patients in internal medicine]E Pautas, M Verny, J Holstein, et al.
Presse Medicale (Paris, France : 1983)|May 29, 2000
[Myasthenia in the aged: a case with unusually late onset]E Pautas, O Milleron, J P Bouchon, et al.
Neuroscience Letters|November 13, 1990
Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and agingJ J Hauw, M Verny, P Delaère, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammonium-propyl-cyclam, and N-[Triethylammonium]-3-propyl-[15]ane-N5, potential cartilage imaging agentsJ C Maurizis, M Rapp, C Nicolas, et al.
Acta Neuropathologica|January 1, 1996
Progressive supranuclear palsy: a clinicopathological study of 21 casesM Verny, K A Jellinger, J J Hauw, et al.
Pageof 7